The Antidepressant Sertraline Provides a Promising Therapeutic Option for Neurotropic Cryptococcal Infections

被引:160
|
作者
Zhai, Bing [1 ]
Wu, Cheng [1 ]
Wang, Linqi [1 ]
Sachs, Matthew S. [1 ]
Lin, Xiaorong [1 ]
机构
[1] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA
基金
美国国家卫生研究院;
关键词
SEROTONIN REUPTAKE INHIBITORS; OBSESSIVE-COMPULSIVE DISORDER; CENTRAL-NERVOUS-SYSTEM; IN-VITRO; ANTIFUNGAL ACTIVITY; DRUG DEVELOPMENT; AMPHOTERICIN-B; FLUCONAZOLE; NEOFORMANS; TARGET;
D O I
10.1128/AAC.00212-12
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Therapeutic treatment for systemic mycoses is severely hampered by the extremely limited number of antifungals. The difficulty of treatment of fungal infections in the central nervous system is further compounded by the poor central nervous system (CNS) penetration of most antifungals due to the blood-brain barrier. Only a few fungistatic azole drugs, such as fluconazole, show reasonable CNS penetration. Here we demonstrate that sertraline (Zoloft), the most frequently prescribed antidepressant, displays potent antifungal activity against Cryptococcus neoformans, the major causative agent of fungal meningitis. In in vitro assays, this neurotropic drug is fungicidal to all natural Cryptococcus isolates tested at clinically relevant concentrations. Furthermore, sertraline interacts synergistically or additively with fluconazole against Cryptococcus. Importantly, consistent with our in vitro observations, sertraline used alone reduces the brain fungal burden at an efficacy comparable to that of fluconazole in a murine model of systemic cryptococcosis. It works synergistically with fluconazole in reducing the fungal burden in brain, kidney, and spleen. In contrast to its potency against Cryptococcus, sertraline is less effective against strains of Candida species and its interactions with fluconazole against Candida strains are often antagonistic. Therefore, our data suggest the unique application of sertraline against cryptococcosis. To understand the antifungal mechanisms of sertraline, we screened a whole-genome deletion collection of Saccharomyces cerevisiae for altered sertraline susceptibility. Gene ontology analyses of selected mutations suggest that sertraline perturbs translation. In vitro translation assays using fungal cell extracts show that sertraline inhibits protein synthesis. Taken together, our findings indicate the potential of adopting this antidepressant in treating cryptococcal meningitis.
引用
收藏
页码:3758 / 3766
页数:9
相关论文
共 50 条
  • [11] Oligonucleotides-A Novel Promising Therapeutic Option for IBD
    Scarozza, Patrizio
    Schmitt, Heike
    Monteleone, Giovanni
    Neurath, Markus F.
    Atreya, Raja
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [12] Is β-interferon a promising therapeutic option for the management of hepatitis C?
    Hosseini-Moghaddam, Seyed Mohammadmehdi
    Mousavi, Afkham
    Alavian, Seyed Moayed
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1097 - 1103
  • [13] Methotrexate - a promising therapeutic Option for Patients with ulcerative Colitis?
    Hartl, J.
    Klebl, F.
    Mueller-Schilling, M.
    Ott, C.
    INTERNIST, 2013, 54 : 23 - 23
  • [14] Liposome-loaded phage cocktail: a promising therapeutic option against postsurgical wound infections - a critical appraisal
    Easwaran, Maheswaran
    Raja, Nageshwari
    Saravanan, Muthupandian
    Belete, Melaku Ashagrie
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (08): : 4319 - 4321
  • [15] Tigecycline as a therapeutic option in Stenotrophomonas maltophilia infections
    Tekce, Yasemin Tezer
    Erbay, Ayse
    Cabadak, Hatice
    Sen, Suha
    JOURNAL OF CHEMOTHERAPY, 2012, 24 (03) : 150 - 154
  • [16] Anidulafungin: is it a promising option in the treatment of pediatric invasive fungal infections?
    Tapisiz, Anil
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (03) : 339 - 346
  • [17] Efficacy of tocilizumab in adult H syndrome: a promising therapeutic option
    Hamann, Pierre
    Moguelet, Philippe
    Chasset, Francois
    Delaleu, Jeremie
    Barbaud, Annick
    Senet, Patricia
    Frances, Camille
    De Risi-Pugliese, Tullia
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (10) : E417 - E419
  • [18] Insights into the potential of Sanguinarine as a promising therapeutic option for breast cancer
    Malla, Rama Rao
    Bhamidipati, Priyamvada
    Adem, Meghapriya
    BIOCHEMICAL PHARMACOLOGY, 2023, 212
  • [19] Non-steroidal MRA - The new promising Therapeutic Option
    Franke, Katharina
    AKTUELLE KARDIOLOGIE, 2021, 10 (03) : 164 - 164
  • [20] Ivermectin as a promising therapeutic option for onchocerciasis-associated epilepsy
    Manavi, Mohammad Amin
    Mohammad Jafari, Razieh
    Shafaroodi, Hamed
    Sharifzadeh, Mohammad
    Dehpour, Ahmad Reza
    EPILEPSIA OPEN, 2024,